COVADIS Pilot Trial: COseal in Ventricular Assist DevIceS (COVADIS)
A Controlled, Single-Center Clinical Pilot Study to Evaluate the Performance of CoSeal as a Barrier for Adhesion Prevention in Patients Submitted to Ventricular Assist Device VAD)
Sponsor: Baxter Healthcare Corporation
Listed as NCT01244321, this observational or N/A phase trial focuses on End-stage Heart Failure Awaiting VAD Implantation and remains ongoing. Sponsored by Baxter Healthcare Corporation, it has been updated 7 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
▶ Show 2 earlier versions
-
Mar 2018 — Apr 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Dec 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baxter Healthcare Corporation
- German Heart Institute
For direct contact, visit the study record on ClinicalTrials.gov .